Mechanism and biological significance of the overexpression of IFITM3 in gastric cancer.

Interferon‑induced transmembrane protein 3 (IFITM3) has been recently identified as a potential molecular marker. IFITM3 has been reported to be upregulated in various human diseases, including colon and breast cancer, astrocytoma, as well as ulcerative colitis. However, the clinical significance and underlying mechanisms of IFITM3 dysregulated expression in gastric cancer (GC) remain to be determined. The present study aimed to evaluate the expression of IFITM3 in human gastric tumor cells and specimens and investigate the effects of IFITM3 knockdown in the regulation of GC growth and its potential mechanism. IFITM3 expression was significantly overexpressed in the GC cell lines and GC tissues compared with corresponding normal controls by RT‑qPCR, western blot analysis and immunohistochemistry, and this overexpression was correlated with tumor differentiation, lymph node and distant metastasis, and advanced tumor node metastasis stages. Furthermore, knockdown of IFITM3 expression suppressed tumor cell migration, invasion and proliferation significantly in vitro, arrested tumor cells at the G0/G1 phase and reduced the cell numbers in the S phase of the cell cycle. We preliminarily confirmed that IFITM3 can be mediated by the activities of Wnt/β-catenin signaling. Further investigation revealed that silencing of IFITM3 effectively reversed the epithelial-to-mesenchymal transition (EMT) phenotype and reduced the activities of MMP-2 and MMP-9 expression. Taken together, these data suggested that IFITM3 is a potential therapeutic target for GC.

[1]  B. Zhao,et al.  The role of IFITM3 in the growth and migration of human glioma cells , 2013, BMC Neurology.

[2]  Yan Fang,et al.  XAV939, a tankyrase 1 inhibitior, promotes cell apoptosis in neuroblastoma cell lines by inhibiting Wnt/β-catenin signaling pathway , 2013, Journal of experimental & clinical cancer research : CR.

[3]  Yan Fang,et al.  XAV939, a tankyrase 1 inhibitior, promotes cell apoptosis in neuroblastoma cell lines by inhibiting Wnt/β-catenin signaling pathway , 2013, Journal of Experimental & Clinical Cancer Research.

[4]  Hongwen Gao,et al.  Knockdown of interferon-induced transmembrane protein 3 expression suppresses breast cancer cell growth and colony formation and affects the cell cycle. , 2013, Oncology reports.

[5]  Zi-fang Song,et al.  Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition. , 2013, Carcinogenesis.

[6]  Yanqing Ding,et al.  Metastasis-associated factors facilitating the progression of colorectal cancer. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[7]  Ke Ma,et al.  LARP7 is a potential tumor suppressor gene in gastric cancer , 2012, Laboratory Investigation.

[8]  Sophia Hsin-Jung Li,et al.  Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast , 2011, Cell.

[9]  Qiang Li,et al.  KLF4-Mediated Negative Regulation of IFITM3 Expression Plays a Critical Role in Colon Cancer Pathogenesis , 2011, Clinical Cancer Research.

[10]  Heidi Ledford.  Cancer theory faces doubts , 2011, Nature.

[11]  C. Gialeli,et al.  Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting , 2011, The FEBS journal.

[12]  Haitao Guo,et al.  Identification of Five Interferon-Induced Cellular Proteins That Inhibit West Nile Virus and Dengue Virus Infections , 2010, Journal of Virology.

[13]  P. Johnston,et al.  Interferon-induced transmembrane 3 binds osteopontin in vitro: expressed in vivo IFITM3 reduced OPN expression , 2010, Oncogene.

[14]  V. Rotter,et al.  The human 1‐8D gene (IFITM2) is a novel p53 independent pro‐apoptotic gene , 2009, International journal of cancer.

[15]  M. Moses,et al.  Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Jacques Ferlay,et al.  Recent patterns in gastric cancer: A global overview , 2009, International journal of cancer.

[17]  Rod K. Nibbe,et al.  Discovery and Scoring of Protein Interaction Subnetworks Discriminative of Late Stage Human Colon Cancer*S , 2009, Molecular & Cellular Proteomics.

[18]  Takashi Takata,et al.  IFN-Induced Transmembrane Protein 1 Promotes Invasion at Early Stage of Head and Neck Cancer Progression , 2008, Clinical Cancer Research.

[19]  Ron Orlando,et al.  Up-regulation of NG2 proteoglycan and interferon-induced transmembrane proteins 1 and 3 in mouse astrocytoma: a membrane proteomics approach. , 2008, Cancer letters.

[20]  J. Weis,et al.  Expression of the mouse fragilis gene products in immune cells and association with receptor signaling complexes , 2006, Genes and Immunity.

[21]  P. Laurent-Puig,et al.  Identification of the IFITM family as a new molecular marker in human colorectal tumors. , 2006, Cancer research.

[22]  P. Tam,et al.  IFITM/Mil/fragilis family proteins IFITM1 and IFITM3 play distinct roles in mouse primordial germ cell homing and repulsion. , 2005, Developmental cell.

[23]  C. Wylie.  IFITM1-mediated cell repulsion controls the initial steps of germ cell migration in the mouse. , 2005, Developmental cell.

[24]  R. Nusse,et al.  The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.

[25]  Y. Matsui,et al.  Regulation of expression of mouse interferon‐induced transmembrane protein like gene‐3, Ifitm3 (mil‐1, fragilis), in germ cells , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[26]  M. Surani,et al.  Specification of germ cell fate in mice. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[27]  M. Surani,et al.  The Fragilis interferon-inducible gene family of transmembrane proteins is associated with germ cell specification in mice , 2003, BMC Developmental Biology.

[28]  M. Surani,et al.  A molecular programme for the specification of germ cell fate in mice , 2002, Nature.

[29]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[30]  T. Koga,et al.  Clinicopathological features and overexpression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  S. Gollnick,et al.  Interferon-alpha induces the expression of the L-selectin homing receptor in human B lymphoid cells , 1993, The Journal of cell biology.

[32]  G. Stark,et al.  Molecular analysis of a human interferon-inducible gene family. , 1991, European journal of biochemistry.

[33]  G. Stark,et al.  Differential regulation of interferon-induced mRNAs and c-myc mRNA by α- and γ-interferons , 1985 .

[34]  G. Stark,et al.  Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells , 1984, Cell.

[35]  Yan Zhao,et al.  Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation. , 2014, Oncology reports.

[36]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[37]  P. García Alfonso,et al.  Management of gastric adenocarcinoma , 2007, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[38]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.